Correction
- PMID: 35973906
- DOI: 10.1016/j.cgh.2022.07.003
Correction
Erratum for
-
Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial.Clin Gastroenterol Hepatol. 2022 Mar;20(3):525-534.e10. doi: 10.1016/j.cgh.2021.04.022. Epub 2021 Apr 19. Clin Gastroenterol Hepatol. 2022. PMID: 33887475 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources